Eargo, Inc. (Nasdaq: EAR), relating to its proposed sale to an affiliate of Patient Square Capital. Under the terms of the agreement, EAR shareholders will receive $2.55 in cash per share they own.
Eargo, Inc. (Nasdaq: EAR), relating to its proposed sale to an affiliate of Patient Square Capital. Under the terms of the agreement, EAR shareholders will receive $2.55 in cash per share they own.